This Article Full Text (PDF) All Versions of this Article: 1756283X09338431v1 2/5/281    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Troy, P. J. Articles by Waxman, A. B. Social Bookmarking                         What's this?

Review: Portopulmonary hypertension: challenges in diagnosis and management

Pulmonary and Critical Care Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA, abwaxman{at}partners.org

Aaron B. Waxman

Patrick J. Troy Pulmonary and Critical Care Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA

Portopulmonary hypertension is defined as the combination of pulmonary arterial hypertension with portal hypertension and presents management complications in patients awaiting liver transplantation. The combination of these vascular disorders has a marked impact on mortality. At present the recommendations for management are limited because of the paucity of definitive clinical trials. We have reviewed the available data on prevalence, diagnosis and treatment. It is clearly time to more formally approach the study of this patient population.

Key Words: pulmonary hypertension • portal hypertension • liver disease • portopulmonary hypertension • vasodilators

This version was published on September 1, 2009

Therapeutic Advances in Gastroenterology, Vol. 2, No. 5, 281-286 (2009)
DOI: 10.1177/1756283X09338431


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?